Published in Lab Business Week, June 3rd, 2007
"This decision by Bristol-Myers Squibb is an important validation of Asterand's products and services," says Asterand CEO Martyn Coombs. "Our goal is to assist Bristol-Myers Squibb and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.